Transcripts

Lantern Pharma (LTRN) earnings call transcripts

Earnings call transcripts for Lantern Pharma Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    The call reframed Lantern as two capital-efficient growth engines, with LP300 refinement and Open Medicine AI commercialization driving the next phase.

    Aug 14, 2026Confident0.78